$2.64
0.04[1.54%]
At close: Apr 23
Kiromic BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kiromic BioPharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/13/2024 | AM | KRBP | Q1 | -$6.17 | — | — | — | $0.00 | — | — | — | Get Alert |
05/07/2024 | PM | KRBP | Q4 | -$11.02 | — | — | — | $0.00 | — | — | — | Get Alert |
11/14/2023 | PM | KRBP | Q3 | -$22.50 | — | -$1.52 | — | $0.00 | — | $0.00 | — | Get Alert |
08/14/2023 | PM | KRBP | Q2 | -$16.20 | — | -$3.22 | — | $0.00 | — | $0.00 | — | Get Alert |
05/15/2023 | AM | KRBP | Q1 | -$14.40 | — | -$6.17 | — | $0.00 | — | $0.00 | — | Get Alert |
04/17/2023 | PM | KRBP | Q4 | -$21.00 | -$16.80 | -$11.02 | 34.40% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | PM | KRBP | Q3 | -$12.00 | — | -$22.50 | — | $0.00 | — | $0.00 | — | Get Alert |
08/12/2022 | PM | KRBP | Q2 | -$20.40 | — | -$16.20 | — | $0.00 | — | $0.00 | — | Get Alert |
05/13/2022 | AM | KRBP | Q1 | -$15.90 | — | -$14.40 | — | $0.00 | — | $0.00 | — | Get Alert |
04/08/2022 | PM | KRBP | Q4 | -$0.90 | — | -$22.80 | — | $0.00 | — | $0.00 | — | Get Alert |
03/11/2022 | PM | KRBP | Q3 | -$19.50 | — | -$12.00 | — | $0.00 | — | $0.00 | — | Get Alert |
08/13/2021 | AM | KRBP | Q2 | — | — | -$20.40 | — | — | — | $0.00 | — | Get Alert |
05/14/2021 | AM | KRBP | Q1 | — | — | -$15.90 | — | — | — | $0.00 | — | Get Alert |
03/31/2021 | PM | KRBP | Q4 | — | — | -$0.90 | — | — | — | $0.00 | — | Get Alert |
11/30/2020 | PM | KRBP | Q3 | — | — | -$19.50 | — | — | — | $0.00 | — | Get Alert |
Kiromic BioPharma (KRBP) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
The Actual EPS was $-1.52, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.